'New' Biohaven up 81% days after Pfizer acquisition as investors see pipeline potential

Retrieved on: 2022-10-06 17:42:45

Tags for this article:

Click the tags to see associated articles and topics

'New' Biohaven up 81% days after Pfizer acquisition as investors see pipeline potential. View article details on hiswai:

Excerpt

Although Pfizer completed its acquisition of Biohaven Pharmaceutical, the company lives on as a separately traded company, Biohaven Ltd., ...

Article found on: seekingalpha.com